Adiquit is an evidence-based, scientifically validated, interactive, personalized, user-friendly mobile app for quitting smoking. More than 30.000 users evaluated the app.
Adiquit uses innovative, evidence-based on-line therapy approach that follows therapeutic guidelines. Adiquit helps people to quit smoking for good and is a perfect fit into personalized medicine trends. Using Adiquit gives you six times greater chance to quit by adjusting the quitting process to your needs. Adiquit was validated in 3 RCT studies (Norway and Czech Republic) including 1200 smokers proving 30% efficiency.
We want to maximize on our recent momentum , expand to the international markets and reach out mainly to English, German and Spanish speaking countries.
Pfarma companies - Pfizer, Novartis, J&J; Private insurance companies - Allianz, ERAG, ERGO, Munich RE, Hannover RE, Generali, Debeka, R+V, Wiener Stadtische; Health insurance - TK, AOK, Barmer GEK; Pharmacies - Phoenix Group
Challenges / Needs
German & Austrian market entry support
Reference projects / Existing partnerships
Adiquit cooperates with corporates and SMEs. Successful stories involve workshops and smoke-free company concepts in Vodafone, Hyundai, SAP, Raiffeisen or Axa. The application can be reimbursed via Edenred or Sodexo programmes.